<?xml version='1.0' encoding='utf-8'?>
<document id="17893418"><sentence text="Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients." /><sentence text="The effect of a clinical pharmacist's interventions on the duration of antiretroviral-related errors in hospitalized patients was studied" /><sentence text="" /><sentence text="Between August 4, 2005, and February 4, 2006, all patients at least 18 years of age who were admitted to a 651-bed tertiary care teaching hospital and prescribed highly active antiretroviral therapy (HAART) were identified by one clinical pharmacist" /><sentence text=" If a HAART error was suspected, the pharmacist intervened with the house staff or outpatient physician to discuss and resolve the problem" /><sentence text=" The pharmacist also retrospectively identified potential HAART errors among patients with human immunodeficiency virus (HIV) admitted between January 2 and June 30, 2005" /><sentence text=" HAART errors included the following: incomplete regimen, incorrect dosage, incorrect schedule, medication-disease interaction, incorrect formulation, incorrect antiretroviral, duplication of therapy, and drug-drug interaction" /><sentence text=" The duration of each error was measured from the time of the initial incorrect order until a correct order was placed or until the patient was discharged" /><sentence text="" /><sentence text="A total of 199 admissions for patients with an order for HAART were identified during the study periods" /><sentence text=" A total of 73 HAART errors were confirmed in 41 patients" /><sentence text=" The most common type of error was incomplete regimen" /><sentence text=" There was no significant difference in the frequency or type of prescribing when comparing the preintervention and intervention phases" /><sentence text=" The median length of time until an error was corrected, however, was significantly shorter during the intervention phase (15" /><sentence text="5 hours) than the preintervention phase (84 hours) (p &lt; 0" /><sentence text="0001)" /><sentence text="" /><sentence text="The duration of prescribing errors was decreased when a clinical pharmacist monitoring patients receiving HAART intervened to resolve errors" /><sentence text="" /></document>